Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Spinal Diseases HELP
Based on 42,682 articles published since 2008
|||| 10 

These are the 42682 published articles about Spinal Diseases that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
51 Guideline [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms]. 2014

Kiltz, U / Rudwaleit, M / Sieper, J / Krause, D / Chenot, J-F / Stallmach, A / Jaresch, S / Oberschelp, U / Schneider, E / Swoboda, B / Böhm, H / Heiligenhaus, A / Pleyer, U / Böhncke, W-H / Stemmer, M / Braun, J / Anonymous1880805. ·Deutsche Gesellschaft für Rheumatologie (DGRh), -, -, Uta.Kiltz@elisabethgruppe.de. ·Z Rheumatol · Pubmed #25181971.

ABSTRACT: -- No abstract --

52 Guideline [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 2 Preamble]. 2014

Kiltz, U / Sieper, J / Rudwaleit, M / Kellner, H / Krause, D / Böhle, E / Böhm, H / Böhncke, W-H / Chenot, J-F / Heiligenhaus, A / Hermann, K-G / Jaresch, S / Mau, W / Oberschelp, U / Pleyer, U / Repschläger, U / Schneider, E / Smolenski, U / Stallmach, A / Stemmer, M / Swoboda, B / Ulrich, C / Winking, M / Braun, J / Anonymous1860805. ·Deutsche Gesellschaft für Rheumatologie (DGRh), -, -, Uta.Kiltz@elisabethgruppe.de. ·Z Rheumatol · Pubmed #25181970.

ABSTRACT: -- No abstract --

53 Guideline [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 1 Introduction/preliminary comments]. 2014

Kiltz, U / Sieper, J / Rudwaleit, M / Kellner, H / Krause, D / Böhle, E / Böhm, H / Böhncke, W-H / Chenot, J-F / Heiligenhaus, A / Hermann, K-G / Jaresch, S / Mau, W / Oberschelp, U / Pleyer, U / Repschläger, U / Schneider, E / Smolenski, U / Stallmach, A / Stemmer, M / Swoboda, B / Ulrich, C / Winking, M / Braun, J / Anonymous1850805. ·Deutsche Gesellschaft für Rheumatologie (DGRh), -, -, Uta.Kiltz@elisabethgruppe.de. ·Z Rheumatol · Pubmed #25181969.

ABSTRACT: -- No abstract --

54 Guideline [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: Editorial]. 2014

Kiltz, U / Braun, J / Anonymous1840805. ·Rheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland, Uta.Kiltz@elisabethgruppe.de. ·Z Rheumatol · Pubmed #25181968.

ABSTRACT: -- No abstract --

55 Guideline Psoriasis: guidance on assessment and referral. 2014

Samarasekera, Eleanor J / Smith, Catherine H / Anonymous1571028 / Anonymous1581028. ·National Clinical Guideline Centre, Royal College of Physicians of London. ·Clin Med (Lond) · Pubmed #24715130.

ABSTRACT: This concise guideline summarises the key recommendations from the recent National Institute for Health and Care Excellence (NICE) clinical guideline on the assessment and management of psoriasis (CG153) that are relevant to the non-dermatologist. The aim is to highlight important considerations for assessment and referral of people with psoriasis, including identification of relevant comorbid conditions. Psoriasis is a common inflammatory skin condition and, especially when severe, can be associated with increased risk of cardiovascular disease, diabetes and depression. Functional, psychological and social morbidity can also be encountered, and the extent of the disability is frequently underestimated. Importantly, highly effective treatments are available. Appropriate assessment and referral of people with psoriasis therefore has the potential to improve outcomes by correctly identifying the appropriate treatment pathway. Assessment should involve not only disease severity but also the impact on patient well-being and whether the patient has any comorbid conditions, such as psoriatic arthritis, which requires rapid referral to a rheumatologist.

56 Guideline Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). 2014

Robinson, Philip C / Bird, Paul / Lim, Irwin / Saad, Nivene / Schachna, Lionel / Taylor, Andrew L / Whittle, Samuel L / Brown, Matthew A. ·University of Queensland Diamantina Institute, Brisbane, Queensland, Australia; Department of Rheumatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. ·Int J Rheum Dis · Pubmed #24673897.

ABSTRACT: AIM: Non-radiographic axial spondyloarthritis (nr-axSpA) is axial inflammatory arthritis where plain radiographic damage is not evident. An unknown proportion of these patients will progress to ankylosing spondylitis (AS). The increasing recognition of nr-axSpA has been greatly assisted by the widespread use of magnetic resonance imaging. The aim of this article was to construct a set of consensus statements based on a literature review to guide investigation and promote best management of nr-axSpA. METHODS: A literature review using Medline was conducted covering the major investigation modalities and treatment options available. A group of rheumatologists and a radiologist with expertise in investigation and management of SpA reviewed the literature and formulated a set of consensus statements. The Grade system encompassing the level of evidence and strength of recommendation was used. The opinion of a patient with nr-axSpA and a nurse experienced in the care of SpA patients was also sought and included. RESULTS: The literature review found few studies specifically addressing nr-axSpA, or if these patients were included, their results were often not separately reported. Fourteen consensus statements covering investigation and management of nr-axSpA were formulated. The level of agreement was high and ranged from 8.1 to 9.8. Treatment recommendations vary little with established AS, but this is primarily due to the lack of available evidence on the specific treatment of nr-axSpA. CONCLUSION: The consensus statements aim to improve the diagnosis and management of nr-axSpA. We aim to raise awareness of this condition by the public and doctors and promote appropriate investigation and management.

57 Guideline Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study. 2014

Cañete, J D / Daudén, E / Queiro, R / Aguilar, M D / Sánchez-Carazo, J L / Carrascosa, J M / Carretero, G / García-Vivar, M L / Lázaro, P / López-Estebaranz, J L / Montilla, C / Ramírez, J / Rodríguez-Moreno, J / Puig, L. ·Servicio de Reumatología, Hospital Clínic de Barcelona e IDIBAPS, Barcelona, Spain. · Servicio de Dermatología, IIS-Princesa, Hospital Universitario La Princesa, Madrid, Spain. · Servicio de Reumatología, Hospital Universitario Central de Asturias, Oviedo, Spain. · Técnicas Avanzadas de Investigación en Servicios de Salud (TAISS), Madrid, Spain. · Servicio de Dermatología, Hospital General de Valencia, Valencia, Spain. · Servicio de Dermatología, Hospital Universitari Germans Trias y Pujol, Badalona, Barcelona, Spain. · Servicio de Dermatología, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Spain. · Servicio de Reumatología, Hospital Universitario Basurto, Bilbao, Spain. · Servicio de Dermatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain. · Servicio de Reumatología, Hospital Universitario de Salamanca, Salamanca, Spain. · Servicio de Reumatología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. · Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: lpuig@santpau.cat. ·Actas Dermosifiliogr · Pubmed #24657018.

ABSTRACT: Psoriatic arthritis, a chronic inflammatory musculoskeletal disease that is associated with psoriasis, causes joint erosions, accompanied by loss of function and quality-of-life. The clinical presentation is variable, with extreme phenotypes that can mimic rheumatoid arthritis or ankylosing spondylitis. Because psoriasis usually presents before psoriatic arthritis, the dermatologist plays a key role in early detection of the latter. As many treatments used in psoriasis are also used in psoriatic arthritis, treatment recommendations should take into consideration the type and severity of both conditions. This consensus paper presents guidelines for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists. The paper was drafted by a multidisciplinary group (6rheumatologists, 6dermatologists, and 2epidemiologists) using the Delphi method and contains recommendations, tables, and algorithms for the diagnosis, referral, and treatment of patients with psoriatic arthritis.

58 Guideline Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. 2014

Wendling, Daniel / Lukas, Cédric / Paccou, Julien / Claudepierre, Pascal / Carton, Laurence / Combe, Bernard / Goupille, Philippe / Guillemin, Francis / Hudry, Christophe / Miceli-Richard, Corinne / Dougados, Maxime / Anonymous2320781. ·Service de rhumatologie, université de Franche-Comté (EA 4266), CHRU de Besançon, boulevard Fleming, 25030 Besançon, France. Electronic address: dwendling@chu-besancon.fr. · Hôpital Lapeyronie, Montpellier, Institut Universitaire de Recherche Clinique (EA2415), 34000 Montpellier, France. · Département de rhumatologie, CHU d'Amiens, 80000 Amiens, France; Inserm U1088, UFR Médecine/Pharmacie, Université de Picardie Jules-Verne, 80000 Amiens, France. · Université Paris Est Créteil, Laboratoire d'Investigation Clinique (LIC) EA4393, 94010 Créteil, France; AP-HP, Hôpital Henri-Mondor, Service de Rhumatologie, 94000 Créteil, France. · Association France Spondylarthrites, 19000 Tulle, France. · Departement de Rhumatologie, CHU Lapeyronie,Université Montpellier 1, 34000 Montpellier, France. · CHRU de Tours, service de rhumatologie, UMR CNRS 7292, Université François-Rabelais de Tours, 37000 Tours, France. · Inserm CIC-EC, CHU de Nancy, Service épidémiologie et évaluation cliniques, 54505 Nancy, France. · Cabinet de Rhumatologie, 75008 Paris, France. · Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, 94270 Le Kremlin-Bicêtre, France. · Paris-Descartes University, Medicine Faculty, AP-HP, Cochin hospital, Rheumatology B Department, 75014 Paris, France. ·Joint Bone Spine · Pubmed #24412120.

ABSTRACT: OBJECTIVE: To develop practice guidelines for the everyday management of patients with spondyloarthritis (including psoriatic arthritis), by updating previous national and international recommendations, based on a review of recently published data. METHODS: A task force and a multidisciplinary literature review group were established. The task force identified the issues that remained unresolved. Based on existing recommendations and recent publications, the task force developed practice guidelines, which were revised by the literature review group and graded according to AGREE. RESULTS: Practice guidelines for the management of spondyloarthritis are reported. After a review of the general diagnostic principles, 30 practice guidelines are given: 5 on general principles, 4 on the management strategy, 5 on non-pharmacological treatments, 7 on conventional pharmacological treatments, 6 on biotherapies, and 3 on surgical treatments and follow-up. CONCLUSION: The updated practice guidelines reported here constitute a global framework that can guide physicians in the everyday management of spondyloarthritis.

59 Guideline Standards of care for patients with spondyloarthritis. 2014

Abad, Miguel Ángel / Ariza, Rafael Ariza / Aznar, Juan José / Batlle, Enrique / Beltrán, Emma / de Dios Cañete, Juan / de Miguel, Eugenio / Escudero, Alejandro / Fernández-Carballido, Cristina / Gratacós, Jordi / Loza, Estíbaliz / Linares, Luis Francisco / Montilla, Carlos / Ramos, Manuel Moreno / Mulero, Juan / Queiro, Rubén / Raya, Enrique / Lozano, Carlos Rodríguez / Moreno, Jesús Rodríguez / Sanz, Jesús / Silva-Fernández, Lucía / Torre Alonso, Juan Carlos / Zarco, Pedro / Fernández-Sueiro, José Luis / Juanola, Xavier / Anonymous3640780 / Anonymous3650780. ·Rheumatology Unit, Hospital Virgen del Puerto, Plasencia, Spain. ·Rheumatol Int · Pubmed #24390635.

ABSTRACT: To define and give priory to standards of care in patients with spondyloarthritis (SpA). A systematic literature review on SpA standards of care and a specific search in relevant and related sources was performed. An expert panel was established who developed the standards of care and graded their priority (high, mild, low, or no priority) following qualitative methodology and Delphi process. An electronic survey was sent to a representative sample of 167 rheumatologists all around the country, who also gave priority to the standards of care (same scale). A descriptive analysis is presented. The systematic literature review retrieved no article specifically related to SpA patients. A total of 38 standards of care were obtained-12 related to structure, 20 to process, and 6 to result. Access to care, treatment, and safety standards of care were given a high priority by most of rheumatologists. Standards not directly connected to daily practice were not given such priority, as standards which included a time framework. The standards generated for the performance evaluation (including patient and professionals satisfaction) were not considered especially important in general. This set of standards of care should help improve the quality of care in SpA patients.

60 Guideline Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. 2014

Levy-Clarke, Grace / Jabs, Douglas A / Read, Russell W / Rosenbaum, James T / Vitale, Albert / Van Gelder, Russell N. ·St. Luke's Cataract and Laser Institute, Tarpon Springs, Florida. · Departments of Ophthalmology and Medicine, the Mount Sinai Medical School, New York, New York; Department of Epidemiology, the Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. · Department of Ophthalmology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama. · Departments of Ophthalmology and Medicine, Division of Rheumatology, Oregon Health & Science University, Portland, Oregon; Department of Ophthalmology, Legacy Devers Eye Institute, Portland, Oregon. · Department of Ophthalmology, Moran Eye Institute, University of Utah School of Medicine, Salt Lake City, Utah. · Departments of Ophthalmology, Pathology, and Biological Structure, University of Washington School of Medicine, Seattle, Washington. Electronic address: russvg@u.washington.edu. ·Ophthalmology · Pubmed #24359625.

ABSTRACT: TOPIC: To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α) biologic agents in patients with ocular inflammatory disorders. CLINICAL RELEVANCE: Ocular inflammatory diseases remain a leading cause of vision loss worldwide. Anti-TNF-α agents are used widely in treatment of rheumatologic diseases. A committee of the American Uveitis Society performed a systematic review of literature to generate guidelines for use of these agents in ocular inflammatory conditions. METHODS: A systematic review of published studies was performed. Recommendations were generated using the Grading of Recommendations Assessment, Development, and Evaluation group criteria. RESULTS: Numerous studies including controlled clinical trials have demonstrated that anti-TNF-α biologic agents (in particular infliximab and adalimumab) are effective in the treatment of severe ocular inflammatory disease. Based on these studies, the expert panel makes the following recommendations. CONCLUSIONS: Infliximab and adalimumab can be considered as first-line immunomodulatory agents for the treatment of ocular manifestations of Behçet's disease. Infliximab and adalimumab can be considered as second-line immunomodulatory agents for the treatment of uveitis associated with juvenile arthritis. Infliximab and adalimumab can be considered as potential second-line immunomodulatory agents for the treatment of severe ocular inflammatory conditions including posterior uveitis, panuveitis, severe uveitis associated with seronegative spondyloarthropathy, and scleritis in patients requiring immunomodulation in patients who have failed or who are not candidates for antimetabolite or calcineurin inhibitor immunomodulation. Infliximab and adalimumab can be considered in these patients in preference to etanercept, which seems to be associated with lower rates of treatment success.

61 Guideline Position statement on percutaneous vertebral augmentation: a consensus statement developed by the Society of Interventional Radiology (SIR), American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), American College of Radiology (ACR), American Society of Neuroradiology (ASNR), American Society of Spine Radiology (ASSR), Canadian Interventional Radiology Association (CIRA), and the Society of NeuroInterventional Surgery (SNIS). 2014

Barr, John D / Jensen, Mary E / Hirsch, Joshua A / McGraw, J Kevin / Barr, Robert M / Brook, Allan L / Meyers, Philip M / Munk, Peter L / Murphy, Kieran J / O'Toole, John E / Rasmussen, Peter A / Ryken, Timothy C / Sanelli, Pina C / Schwartzberg, Marc S / Seidenwurm, David / Tutton, Sean M / Zoarski, Gregg H / Kuo, Michael D / Rose, Steven C / Cardella, John F / Anonymous3500778 / Anonymous3510778 / Anonymous3520778 / Anonymous3530778 / Anonymous3540778 / Anonymous3550778 / Anonymous3560778 / Anonymous3570778. ·California Center for Neurointerventional Surgery, La Jolla. Electronic address: jb@calcns.com. · Department of Radiology, University of Virginia Health System, Charlottesville, Virginia. · Division of Neurointerventional Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Riverside Interventional Consultants, Riverside Methodist Hospital, Columbus. · Mecklenburg Radiology Associates, Charlotte, North Carolina. · Department of Radiology, Montefiore Medical Center, Bronx. · Department of Neurological Surgery, Columbia University College of Physicians and Surgeons. · Department of Radiology, Vancouver General Hospital, Vancouver, British Columbia. · Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada. · Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois. · Cerebrovascular Center and Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Iowa Spine and Brain Institute, Waterloo, Iowa. · Departments of Radiology and Public Health, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York. · Radiology Associates of Central Florida, Leesburg, Florida. · Radiological Associates of Sacramento, Sacramento. · Department of Radiology, Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin. · Department of Neurointerventional Surgery, Christiana Care Health System, Newark, Delaware. · Department of Radiology, University of California, Los Angeles, Medical School, Los Angeles. · Department of Radiology, University of California, San Diego, Medical Center, San Diego, California. · Department of Radiology, Geisinger Health System, Danville, Pennsylvania. ·J Vasc Interv Radiol · Pubmed #24325929.

ABSTRACT: -- No abstract --

62 Guideline An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. 2014

Kreiner, D Scott / Hwang, Steven W / Easa, John E / Resnick, Daniel K / Baisden, Jamie L / Bess, Shay / Cho, Charles H / DePalma, Michael J / Dougherty, Paul / Fernand, Robert / Ghiselli, Gary / Hanna, Amgad S / Lamer, Tim / Lisi, Anthony J / Mazanec, Daniel J / Meagher, Richard J / Nucci, Robert C / Patel, Rakesh D / Sembrano, Jonathan N / Sharma, Anil K / Summers, Jeffrey T / Taleghani, Christopher K / Tontz, William L / Toton, John F / Anonymous4980775. ·Ahwatukee Sports and Spine, 4530 E. Muirwood Dr, Suite 110, Phoenix, AZ 85048-7693, USA. Electronic address: skreiner@ahwatukeesportsandspine.com. · Department of Neurosurgery, Tufts Medical Center, 800 Washington St, Boston, MA 02111-1552, USA. · The College of Human Medicine, Michigan State University, 12662 Riley St, Suite 120, Holland, MI 49424-8023, USA. · Department Neurosurgery, University of Wisconsin Medical School, K4/834 Clinical Science Center, 600 Highland, Madison, WI 53792-0001, USA. · Department of Neurosurgery, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI 53226-3522, USA. · Rocky Mountain Scoliosis and Spine, 2055 High St, Suite 130, Denver, CO 80205-5504, USA. · Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115-6110, USA. · 2918 Calcutt Drive, Midlothian, VA 23113-2681, USA. · 2000 Van Auken Rd, Newark, NY 14513-9221, USA. · 160 Cheyenne Way, Wayne, NJ 07470-4907, USA. · Denver Spine, 7800 E. Orchard Rd, Suite 100, Greenwood Village, CO 80111-2584, USA. · 9120 Bear Claw Way, Madison, WI 53717-2734, USA. · Mayo Clinic Rochester, 200 1st St SW, Eisenberg 8G, Rochester, MN 55905-0001, USA. · VACT Healthcare System, 950 Campbell Ave., Bldg 2, Floor 4, West Haven, CT 06516-2770, USA. · Cleveland Clinic Spine Institute, 9500 Euclid Ave., C21, Cleveland, OH 44195-0001, USA. · 2152 Susquehanna Rd, Abington, PA 19001-4408, USA. · 6322 Gunn Hwy, Tampa, FL 33625-4105, USA. · University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5000, USA. · University of Minnesota, 2450 Riverside Ave. S., Suite R200, Minneapolis, MN 55454-1450, USA. · Spine and Pain Medicine, 2 Mockingbird Drive, Colts Neck, NJ 07722-2228, USA. · NewSouth NeuroSpine, 2470 Flowood Drive, Flowood, MS 39232-9019, USA. · Cumberland Brain and Spine, 3901 Central Pike, Suite 455, Hermitage, TN 37076-3490, USA. · 3413 Mount Ariane Drive, San Diego, CA 92111-3910, USA. · 4866 Hoen Ave., Santa Rosa, CA 95405-7452, USA. ·Spine J · Pubmed #24239490.

ABSTRACT: BACKGROUND CONTEXT: The objective of the North American Spine Society's (NASS) Evidence-Based Clinical Guideline for the Diagnosis and Treatment of Lumbar Disc Herniation with Radiculopathy is to provide evidence-based recommendations to address key clinical questions surrounding the diagnosis and treatment of lumbar disc herniation with radiculopathy. The guideline is intended to reflect contemporary treatment concepts for symptomatic lumbar disc herniation with radiculopathy as reflected in the highest quality clinical literature available on this subject as of July 2011. The goals of the guideline recommendations are to assist in delivering optimum efficacious treatment and functional recovery from this spinal disorder. PURPOSE: To provide an evidence-based educational tool to assist spine specialists in the diagnosis and treatment of lumbar disc herniation with radiculopathy. STUDY DESIGN: Systematic review and evidence-based clinical guideline. METHODS: This guideline is a product of the Lumbar Disc Herniation with Radiculopathy Work Group of NASS' Evidence-Based Guideline Development Committee. The work group consisted of multidisciplinary spine care specialists trained in the principles of evidence-based analysis. A literature search addressing each question and using a specific search protocol was performed on English-language references found in Medline, Embase (Drugs and Pharmacology), and four additional evidence-based databases to identify articles. The relevant literature was then independently rated using the NASS-adopted standardized levels of evidence. An evidentiary table was created for each of the questions. Final recommendations to answer each clinical question were developed via work group discussion, and grades were assigned to the recommendations using standardized grades of recommendation. In the absence of Level I to IV evidence, work group consensus statements have been developed using a modified nominal group technique, and these statements are clearly identified as such in the guideline. RESULTS: Twenty-nine clinical questions were formulated and addressed, and the answers are summarized in this article. The respective recommendations were graded by strength of the supporting literature, which was stratified by levels of evidence. CONCLUSIONS: The clinical guideline has been created using the techniques of evidence-based medicine and best available evidence to aid practitioners in the care of patients with symptomatic lumbar disc herniation with radiculopathy. The entire guideline document, including the evidentiary tables, suggestions for future research, and all the references, is available electronically on the NASS Web site at http://www.spine.org/Pages/PracticePolicy/ClinicalCare/ClinicalGuidlines/Default.aspx and will remain updated on a timely schedule.

63 Guideline Referral strategy for early recognition of axial spondyloarthritis: consensus recommendations from the Hong Kong Society of Rheumatology. 2013

Mok, C C / Tam, L S / Leung, M H / Ying, K Y / To, C H / Lee, K L / Ho, L Y / Yip, M L / Tsui, H S / Chan, T H / Lee, K W / Li, E K M / Anonymous3830773. ·Department of Medicine, Tuen Mun Hospital. ·Int J Rheum Dis · Pubmed #24164836.

ABSTRACT: Low back pain is one of commonest problems prompting a visit to the family physician. Up to 5% of patients with chronic low back pain in the primary care setting are diagnosed as having spondyloarthritis, which includes the prototype disease ankylosing spondylitis. Making a diagnosis of ankylosing spondylitis is often delayed for years, leading to significant pain, impairment of quality of life, disability and productivity loss. A recent breakthrough in the treatment of spondyloarthritis is the anti-tumor necrosis factor-alpha biologics, which lead to rapid relief of pain and inflammation, and improvement in all clinical parameters of the disease. Patients with early spondyloarthritis often respond better than those with late established disease. With proper recognition of inflammatory back pain, and the use of magnetic resonance imaging, spondyloarthritis can now be diagnosed much earlier before features are evident on plain radiographs. Referral to the rheumatologist based on onset of back pain (> 3 months) before the age of 45 years, and an inflammatory nature of the pain, or the presence of human leukocyte antigen-B27, or sacroiliitis by imaging, have been confirmed in multi-center international studies to be a pragmatic approach to enable early diagnosis of spondyloarthritis. This referral strategy has recently been adopted by the Hong Kong Society of Rheumatology for primary care physicians and non-rheumatology specialists.

64 Guideline Recommendations for the management and treatment of ankylosing spondylitis. 2013

Sampaio-Barros, Percival Degrava / Keiserman, Mauro / Meirelles, Eduardo de Souza / Pinheiro, Marcelo de Medeiros / Ximenes, Antonio Carlos / Azevedo, Valderílio Feijó / Bonfiglioli, Rubens / Carneiro, Sueli / Ranza, Roberto / Bernardo, Wanderley Marques / Gonçalves, Célio Roberto / Anonymous1160770. · ·Rev Bras Reumatol · Pubmed #24051908.

ABSTRACT: -- No abstract --

65 Guideline Recommendations for the management and treatment of psoriatic arthritis. 2013

Carneiro, Sueli / Azevedo, Valderílio Feijó / Bonfiglioli, Rubens / Ranza, Roberto / Gonçalves, Célio Roberto / Keiserman, Mauro / Meirelles, Eduardo de Souza / Pinheiro, Marcelo de Medeiros / Ximenes, Antonio Carlos / Bernardo, Wanderley / Sampaio-Barros, Percival Degrava / Anonymous1150770. · ·Rev Bras Reumatol · Pubmed #24051907.

ABSTRACT: -- No abstract --

66 Guideline Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. 2013

Puig, L / Carrascosa, J M / Carretero, G / de la Cueva, P / Lafuente-Urrez, R F / Belinchón, I / Sánchez-Regaña, M / García-Bustínduy, M / Ribera, M / Alsina, M / Ferrándiz, C / Fonseca, E / García-Patos, V / Herrera, E / López-Estebaranz, J L / Marrón, S E / Moreno, J C / Notario, J / Rivera, R / Rodriguez-Cerdeira, C / Romero, A / Ruiz-Villaverde, R / Taberner, R / Vidal, D / Anonymous1050769. ·Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: lpuig@santpau.cat. ·Actas Dermosifiliogr · Pubmed #24018211.

ABSTRACT: Biologic therapy is a well-established strategy for managing moderate and severe psoriasis. Nevertheless, the high cost of such therapy, the relatively short span of clinical experience with biologics, and the abundance of literature now available on these agents have made evidence-based and consensus-based clinical guidelines necessary. The ideal goal of psoriasis treatment is to achieve complete or nearly complete clearing of lesions and to maintain it over time. Failing that ideal, the goal would be to reduce involvement to localized lesions that can be controlled with topical therapy. Although current evidence allows us to directly or indirectly compare the efficacy or risk of primary or secondary failure of available biologics based on objective outcomes, clinical trial findings cannot be directly translated to routine practice. As a result, the prescribing physician must tailor the treatment regimen to the individual patient. This update of the clinical practice guidelines issued by the Spanish Academy of Dermatology and Venereology (AEDV) on biologic therapy for psoriasis incorporates information from the most recent publications on this topic.

67 Guideline [The proposal of Croatian Society for Rheumatology for anti-TNF-alpha therapy in adult patients with spondyloarthritides, 2013]. 2013

Babić-Naglić, Durdica / Grazio, Simeon / Anić, Branimir / Cikes, Nada / Novak, Srdan / Morović-Vergles, Jadranka / Kehler, Tatjana / Marasović-Krstulović, Daniela / Milanović, Sonja / Hanih, Marino / Perić, Porin / Vlako, Tonko / Potocki, Kristina / Curković, Bozidar / Anonymous4700768. ·'Klinika za reumatske bolesti i rehabilitaciju Klinicki bolnicki centar Zagreb. dnaglic@kbc-zagreb.hr ·Reumatizam · Pubmed #24003686.

ABSTRACT: Croatian Society for Rheumatology of Croatian Medical Association updated the proposal for the application of TNF-alpha inhibitors in adult patients with spondyloartritides (SpA) in accordance with the new classification of SpA and european recommendations for the treatment of SpA with biologic agents. In this way a standardized method of diagnosis, targeted treatment, monitoring and evaluating outcomes are proposed.

68 Guideline The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. 2013

Coates, Laura C / Tillett, William / Chandler, David / Helliwell, Philip S / Korendowych, Eleanor / Kyle, Stuart / McInnes, Iain B / Oliver, Susan / Ormerod, Anthony / Smith, Catherine / Symmons, Deborah / Waldron, Nicola / McHugh, Neil J / Anonymous440765. ·Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, UK. neil.mchugh@rnhrd.nhs.uk. ·Rheumatology (Oxford) · Pubmed #23887065.

ABSTRACT: -- No abstract --

69 Guideline An evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spinal stenosis (update). 2013

Kreiner, D Scott / Shaffer, William O / Baisden, Jamie L / Gilbert, Thomas J / Summers, Jeffrey T / Toton, John F / Hwang, Steven W / Mendel, Richard C / Reitman, Charles A / Anonymous1890763. ·Ahwatukee Sports and Spine, 4530 E. Muirwood Drive, Suite 110, Phoenix, AZ 85048-7693, USA. skreiner@ahwatukeesportsandspine.com ·Spine J · Pubmed #23830297.

ABSTRACT: BACKGROUND CONTEXT: The evidence-based clinical guideline on the diagnosis and treatment of degenerative lumbar spinal stenosis by the North American Spine Society (NASS) provides evidence-based recommendations to address key clinical questions surrounding the diagnosis and treatment of degenerative lumbar spinal stenosis. The guideline is intended to reflect contemporary treatment concepts for symptomatic degenerative lumbar spinal stenosis as reflected in the highest quality clinical literature available on this subject as of July 2010. The goals of the guideline recommendations are to assist in delivering optimum efficacious treatment and functional recovery from this spinal disorder. PURPOSE: Provide an evidence-based educational tool to assist spine care providers in improving quality and efficiency of care delivered to patients with degenerative lumbar spinal stenosis. STUDY DESIGN: Systematic review and evidence-based clinical guideline. METHODS: This report is from the Degenerative Lumbar Spinal Stenosis Work Group of the NASS's Evidence-Based Clinical Guideline Development Committee. The work group consisted of multidisciplinary spine care specialists trained in the principles of evidence-based analysis. The original guideline, published in 2006, was carefully reviewed. A literature search addressing each question and using a specific search protocol was performed on English language references found in MEDLINE, EMBASE (Drugs and Pharmacology), and four additional, evidence-based, databases to identify articles published since the search performed for the original guideline. The relevant literature was then independently rated by a minimum of three physician reviewers using the NASS-adopted standardized levels of evidence. An evidentiary table was created for each of the questions. Final recommendations to answer each clinical question were arrived at via work group discussion, and grades were assigned to the recommendations using standardized grades of recommendation. In the absence of Levels I to IV evidence, work group consensus statements have been developed using a modified nominal group technique, and these statements are clearly identified as such in the guideline. RESULTS: Sixteen key clinical questions were assessed, addressing issues of natural history, diagnosis, and treatment of degenerative lumbar spinal stenosis. The answers are summarized in this document. The respective recommendations were graded by the strength of the supporting literature that was stratified by levels of evidence. CONCLUSIONS: A clinical guideline for degenerative lumbar spinal stenosis has been updated using the techniques of evidence-based medicine and using the best available clinical evidence to aid both practitioners and patients involved with the care of this condition. The entire guideline document, including the evidentiary tables, suggestions for future research, and all references, will be available electronically at the NASS Web site (www.spine.org) and will remain updated on a timely schedule.

70 Guideline Adult herniated cervical disc: surgical treatment. 2012

Anonymous2050745 / Anonymous2060745 / Anonymous2070745. · ·Rev Assoc Med Bras (1992) · Pubmed #23250089.

ABSTRACT: -- No abstract --

71 Guideline Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update. 2012

Machado, Pedro / Bernardo, Alexandra / Cravo, Ana Rita / Rodrigues, Ana / Malcata, Armando / Nour, Dolores / Vieira-Sousa, Elsa / Godinho, Fátima / Pimentel, Fernando / Canhão, Helena / Santos, Helena / Cunha, Inês / Fonseca, João Eurico / Costa, José / Costa, Lúcia / Cunha-Miranda, Luís / Maurício, Luís / Cruz, Margarida / Santos, Maria José / Bernardes, Miguel / Bogas, Mónica / Valente, Paula / Ramiro, Sofia / Barcelos, Anabela / Anonymous1630731. ·Serviço de Reumatologia, Hospitais da Universidade de Coimbra, Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal. pedrommcmachado@gmail.com ·Acta Reumatol Port · Pubmed #22781513.

ABSTRACT: OBJECTIVE: To develop recommendations for the treatment of axial spondyloarthritis with biological therapies, endorsed by the Portuguese Society of Rheumatology. METHODS: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. A draft of the recommendations and supporting evidence was first circulated to all Portuguese rheumatologists and their suggestions were incorporated in the draft. Secondly, at a national meeting the recommendations were presented, discussed and revised. Finally, the document resulting from this meeting was again circulated to all Portuguese rheumatologists, who anonymously voted online on the level of agreement with the recommendations. RESULTS: A consensus was achieved regarding the initiation, assessment of response and switching biological therapies in patients with axial spondyloarthritis. CONCLUSION: These recommendations may be used for guidance in deciding which patients with axial spondyloarthritis should be treated with biological therapies. They cover a rapidly evolving area of therapeutic intervention. As more evidence becomes available and more biological therapies are licensed, these recommendations will have to be updated.

72 Guideline 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. 2012

Machado, Pedro / Bogas, Mónica / Ribeiro, Ana / Costa, José / Neto, Adriano / Sepriano, Alexandre / Raposo, Ana / Cravo, Ana Rita / Vilar, António / Furtado, Carolina / Ambrósio, Catarina / Miguel, Cláudia / Vaz, Cláudia / Catita, Cristina / Nour, Dolores / Araújo, Domingos / Vieira-Sousa, Elsa / Teixeira, Filipa / Brandão, Filipe / Canhão, Helena / Cordeiro, Inês / Gonçalves, Inês / Ferreira, Joana / Fonseca, João Eurico / da Silva, José Alberto Pereira / Romeu, José / Ferreira, Júlia / Costa, Lúcia / Maurício, Luís / Cunha-Miranda, Luís / Parente, Manuela / Coutinho, Margarida / Cruz, Margarida / Oliveira, Margarida / Salvador, Maria João / Santos, Maria José / Pinto, Patrícia / Valente, Paula / Abreu, Pedro / Roque, Raquel / Ramiro, Sofia / Capela, Susana / Las, Vera / Barcelos, Anabela / Anonymous1620731. ·Serviço de Reumatologia, Hospitais da Universidade de Coimbra, Praceta Prof. Mota Pinto, 3000-075 Coimbra, Portugal. pedrommcmachado@gmail.com ·Acta Reumatol Port · Pubmed #22781512.

ABSTRACT: OBJECTIVE: To develop recommendations for the treatment of psoriatic arthritis (PsA) with biological therapies, endorsed by the Portuguese Society of Rheumatology. METHODS: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. A draft of the recommendations was first circulated to all Portuguese rheumatologists and their suggestions were incorporated in the draft. At a national meeting the recommendations were discussed and all attending rheumatologists voted on the level of agreement for each recommendation. A second draft was again circulated before publication. RESULTS: A consensus was achieved regarding the initiation, assessment of response and switching biological therapies in patients with PsA. Specific recommendations were developed for several disease domains: peripheral arthritis, axial disease, enthesitis and dactylitis. CONCLUSION: These recommendations may be used for guidance in deciding which patients with PsA should be treated with biological therapies. They cover a rapidly evolving area of therapeutic intervention. As more evidence becomes available and more biological therapies are licensed, these recommendations will have to be updated.

73 Guideline Expert opinion and key recommendations for the physical therapy and rehabilitation of patients with ankylosing spondylitis. 2012

Ozgocmen, Salih / Akgul, Ozgur / Altay, Zuhal / Altindag, Ozlem / Baysal, Ozlem / Calis, Mustafa / Capkin, Erhan / Cevik, Remzi / Durmus, Bekir / Gur, Ali / Kamanli, Ayhan / Karkucak, Murat / Madenci, Ercan / Melikoglu, Meltem A / Nas, Kemal / Senel, Kazim / Ugur, Mahir / Anonymous1730729. ·Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Gevher Nesibe Hospital, Erciyes University, School of Medicine, Kayseri, Turkey. sozgocmen@hotmail.com ·Int J Rheum Dis · Pubmed #22709485.

ABSTRACT: AIM:   Physiotherapy is an integral part of the management of ankylosing spondylitis (AS) and there is a need for recommendations which focus on the rehabilitation of patients with AS. We aimed to develop recommendations for the physical therapy and rehabilitation of patients with AS based on the evidence and expertise. METHODS:   The Anatolian Group for the Assessment in Rheumatic Diseases (ANGARD) is a scientific group of Turkish academicians (physiatrists and rheumatologists) who are experts in the rehabilitation of patients with AS. A systematic literature search summarizing the current available physiotherapy and rehabilitation trials in AS were presented to the experts before a special 2-day meeting. Experts attending this meeting first defined a framework based on the main principles and thereafter collectively constructed six major recommendations on physiotherapy and rehabilitation in AS. After the meeting an email survey was conducted to rate the strength of the recommendations. RESULTS:   Six key recommendations which cover the general principles of rehabilitation in AS in terms of early intervention, initial and follow-up assessments and monitoring, contraindications and precautions, key advice for physiotherapy methods and exercise were constructed. CONCLUSION:   These recommendations were developed using evidence-based data and expert opinion. The implementation of these recommendations should encourage a more comprehensive and methodical approach in the rehabilitation of patients with AS. Regular lifelong exercise is the mainstay of rehabilitation and there is a considerable need for well-designed studies which will enlighten the role of physical therapy in the management of AS.

74 Guideline The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. 2012

Sahgal, A / Roberge, D / Schellenberg, D / Purdie, T G / Swaminath, A / Pantarotto, J / Filion, E / Gabos, Z / Butler, J / Letourneau, D / Masucci, G L / Mulroy, L / Bezjak, A / Dawson, L A / Parliament, M / Anonymous1550727. ·Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada. Arjun.sahgal@rmp.uhn.on.ca ·Clin Oncol (R Coll Radiol) · Pubmed #22633542.

ABSTRACT: AIMS: The Canadian Association of Radiation Oncology-Stereotactic Body Radiotherapy (CARO-SBRT) Task Force was established in 2010. The aim was to define the scope of practice guidelines for the profession to ensure safe practice specific for the most common sites of lung, liver and spine SBRT. MATERIALS AND METHODS: A group of Canadian SBRT experts were charged by our national radiation oncology organisation (CARO) to define the basic principles and technologies for SBRT practice, to propose the minimum technological requirements for safe practice with a focus on simulation and image guidance and to outline procedural considerations for radiation oncology departments to consider when establishing an SBRT programme. RESULTS: We recognised that SBRT should be considered as a specific programme within a radiation department, and we provide a definition of SBRT according to a Canadian consensus. We outlined the basic requirements for safe simulation as they pertain to spine, lung and liver tumours, and the fundamentals of image guidance. The roles of the radiation oncologist, medical physicist and dosimetrist have been detailed such that we strongly recommend the development of SBRT-specific teams. Quality assurance is a key programmatic aspect for safe SBRT practice, and we outline the basic principles of appropriate quality assurance specific to SBRT. CONCLUSION: This CARO scope of practice guideline for SBRT is specific to liver, lung and spine tumours. The task force recommendations are designed to assist departments in establishing safe and robust SBRT programmes.

75 Guideline International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. 2012

Cox, Brett W / Spratt, Daniel E / Lovelock, Michael / Bilsky, Mark H / Lis, Eric / Ryu, Samuel / Sheehan, Jason / Gerszten, Peter C / Chang, Eric / Gibbs, Iris / Soltys, Scott / Sahgal, Arjun / Deasy, Joe / Flickinger, John / Quader, Mubina / Mindea, Stefan / Yamada, Yoshiya. ·Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. coxb@mskcc.org ·Int J Radiat Oncol Biol Phys · Pubmed #22608954.

ABSTRACT: PURPOSE: Spinal stereotactic radiosurgery (SRS) is increasingly used to manage spinal metastases. However, target volume definition varies considerably and no consensus target volume guidelines exist. This study proposes consensus target volume definitions using common scenarios in metastatic spine radiosurgery. METHODS AND MATERIALS: Seven radiation oncologists and 3 neurological surgeons with spinal radiosurgery expertise independently contoured target and critical normal structures for 10 cases representing common scenarios in metastatic spine radiosurgery. Each set of volumes was imported into the Computational Environment for Radiotherapy Research. Quantitative analysis was performed using an expectation maximization algorithm for Simultaneous Truth and Performance Level Estimation (STAPLE) with kappa statistics calculating agreement between physicians. Optimized confidence level consensus contours were identified using histogram agreement analysis and characterized to create target volume definition guidelines. RESULTS: Mean STAPLE agreement sensitivity and specificity was 0.76 (range, 0.67-0.84) and 0.97 (range, 0.94-0.99), respectively, for gross tumor volume (GTV) and 0.79 (range, 0.66-0.91) and 0.96 (range, 0.92-0.98), respectively, for clinical target volume (CTV). Mean kappa agreement was 0.65 (range, 0.54-0.79) for GTV and 0.64 (range, 0.54-0.82) for CTV (P<.01 for GTV and CTV in all cases). STAPLE histogram agreement analysis identified optimal consensus contours (80% confidence limit). Consensus recommendations include that the CTV should include abnormal marrow signal suspicious for microscopic invasion and an adjacent normal bony expansion to account for subclinical tumor spread in the marrow space. No epidural CTV expansion is recommended without epidural disease, and circumferential CTVs encircling the cord should be used only when the vertebral body, bilateral pedicles/lamina, and spinous process are all involved or there is extensive metastatic disease along the circumference of the epidural space. CONCLUSIONS: This report provides consensus guidelines for target volume definition for spinal metastases receiving upfront SRS in common clinical situations.

Back · Next